Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Analgesic with a Range of Therapeutic Applications
DoubleRainbow Biosciences and Landkind to Participate in SupplySide West Conference October 31 - November 4
Double Rainbow Announces Membership with BioMADE
Big Pharma’s Green Ambitions
Kelai pens Double Rainbow pact to pair drug delivery and biosynthesis tech
DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound therapeutics
Landkind launches LK-01 Pure Salidroside for cognitive and athletic performance
Bioengineering the Sustainable Future of Medicinal Plants
Double Rainbow launches Landkind to deliver a new class of sustainable wellness products
Cutting the carbon footprint of pharma’s supply chain
Could Sugar Hold the Key to Cancer?
Pharma Sets a Foundation for Greener API Manufacturing
